Research and Science

The Research and Science team at Axolabs is responsible for driving the innovation and development of nucleic acid therapeutics. This team conducts extensive research in oligonucleotide synthesis and analytics, develops new formulations, and performs in vitro and in vivo analyses to understand the efficacy and safety of these therapies. With expertise in bioinformatics and process development, they support the progression of therapeutic candidates from early-stage research to clinical trials.